CHESTER, N.Y.--(BUSINESS WIRE)--Innovative Health Sciences, LLC (“IHS” or the “Company”) management announced today that IHS has received FDA clearance for its Insignis™ Subcutaneous Needle Sets. This ...
announced today that it has received approval from the Food and Drug Administration (FDA) to begin U.S. marketing of its new Subcutaneous Needle Sets which the company is promoting as the HIgh Flo™ ...
• An in-depth review of the most advanced and popular subcutaneous drug delivery systems, including large volume wearable injectors, autoinjectors, pen injectors, needle-free injectors, drug ...
The LifeSite subcutaneous access system allows immediate hemodialysis after implantation. The device consists of a silicone cannula, which is placed in a central venous location (usually via the right ...
Repro-Med Systems, Inc., announced that it has received approval from the Food and Drug Administration (FDA) to begin US marketing of its new Subcutaneous Needle Sets which the company is promoting as ...
In addition, the study provides an in-depth analysis of the formulation technologies and drug delivery systems (focusing on large volume wearable injectors, autoinjectors, pen injectors, needle-free ...
DUBLIN--(BUSINESS WIRE)--The "Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030" report has been added to ResearchAndMarkets.com's offering. Biologics represent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results